Vaxxinity Stock Shares Owned By Insiders
| VAXXDelisted Stock | USD 2.72 0.19 6.53% |
Vaxxinity fundamentals help investors to digest information that contributes to Vaxxinity's financial success or failures. It also enables traders to predict the movement of Vaxxinity Pink Sheet. The fundamental analysis module provides a way to measure Vaxxinity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxxinity pink sheet.
Vaxxinity |
Vaxxinity Company Shares Owned By Insiders Analysis
Vaxxinity's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Vaxxinity Shares Owned By Insiders | 50.90 % |
Most of Vaxxinity's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxxinity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 50% of Vaxxinity are shares owned by insiders. This is 235.31% higher than that of the Biotechnology sector and 258.96% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Vaxxinity Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxxinity's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vaxxinity could also be used in its relative valuation, which is a method of valuing Vaxxinity by comparing valuation metrics of similar companies.Vaxxinity is currently under evaluation in shares owned by insiders category among its peers.
Vaxxinity Fundamentals
| Return On Equity | -1.51 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (1.39 M) | ||||
| Shares Outstanding | 112.91 M | ||||
| Shares Owned By Insiders | 50.90 % | ||||
| Shares Owned By Institutions | 12.24 % | ||||
| Number Of Shares Shorted | 4.22 M | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 4,605 X | ||||
| Gross Profit | (1.87 M) | ||||
| EBITDA | (56.05 M) | ||||
| Net Income | (56.93 M) | ||||
| Cash And Equivalents | 128.23 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 5.46 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (57.24 M) | ||||
| Short Ratio | 13.97 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Price To Earnings To Growth | 0.05 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 57 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 14.09 M | ||||
| Total Asset | 44.35 M | ||||
| Retained Earnings | (361.64 M) | ||||
| Working Capital | 15.62 M | ||||
| Net Asset | 44.35 M |
About Vaxxinity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxxinity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxxinity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxxinity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |